Error in Author’s Name and Degree - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction to the Fourth Author’s Name and Academic Degree

  • November 1, 2026

Share

Clinical Report: Correction to the Fourth Author’s Name and Academic Degree

Overview

A correction to the Original Investigation “Compartment-Specific Recurrence in Medullary Thyroid Cancer” updated the fourth author’s middle initial and academic degree. Mr Elkersh’s name should include the middle initial “G.” and his degree should be listed as “BS”; the article was corrected online.

Background

Medullary thyroid cancer is the subject of the corrected Original Investigation, but the notice reports a byline error rather than clinical findings. Accurate author names and credentials are important for proper attribution of published research. The correction specifies the affected author details and confirms that the online article was updated.

Data Highlights

The correction notice reports no numerical or trial data. It identifies two byline changes: Mr Elkersh’s middle initial is “G.” and his academic degree is “BS.”

Key Findings

  • The correction concerns the Original Investigation “Compartment-Specific Recurrence in Medullary Thyroid Cancer.”
  • The investigation was published online September 3, 2026, in JAMA Otolaryngology–Head & Neck Surgery.
  • The fourth author’s middle initial was corrected to “G.”
  • The fourth author’s academic degree was corrected to “BS.”
  • The article was corrected online.

Clinical Implications

The notice documents a correction to author identification and credentials, not a change to clinical data or conclusions. No clinical management implications are stated in the correction notice.

Conclusion

The online article now reflects the corrected middle initial and academic degree for its fourth author.

Related Resources & Content

  1. JAMA Otolaryngology–Head & Neck Surgery, 2026 — Correction to the Fourth Author’s Name and Academic Degree
  2. JAMA Network Open — Correction to the Third Author’s Institutional Affiliation
  3. JAMA Surgery — Correction Notice: Author Degree Misspelling in the Article "Whole-Blood Transfusion From Empiricism to Evidence: A Narrative Review
  4. JAMA Internal Medicine — Correction of Author Attribution in "Turnover and Burnout Among Family Physicians" Research Letter
  5. Annals of Family Medicine — Erratum
  6. Compartment-Specific Recurrence in Medullary Thyroid Cancer
  7. Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma The American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma
  8. S3 guidelines on thyroid carcinoma: what’s new? | HNO | Springer Nature Link
  9. Systemic Treatment of Thyroid Cancer: ASCO Guideline
  10. Compartment-Specific Recurrence in Medullary Thyroid Cancer.
  11. Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer
  12. FDA approves selpercatinib for medullary thyroid cancer with a RET mutation | FDA
  13. Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma
  14. Vandetanib for the Treatment of Medullary Thyroid Cancer
  15. Systemic Treatment of Thyroid Cancer: ASCO Guideline

Original Source(s)

Related Content